We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AbCellera and Denali Therapeutics Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies for Neurological Diseases

Product News   Mar 08, 2019

 
AbCellera and Denali Therapeutics Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies for Neurological Diseases

Image credit: AbCellera

FURTHER INFORMATION
 
 
 

Related Product News

3D Cell Culture Scaffolds Provide New Insights Into Myelination

Product News

Scientists at Stanford University Medical School have used the Mimetix® aligned 3D cell culture scaffold supplied by AMSBIO to understand the architecture of the myelin sheaths which insulate neuronal axons.

READ MORE

Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia

Product News

IONTAS has been informed that International Biotechnology Center (IBC) Generium has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B Cell Acute Lymphoblastic Leukemia (ALL).

READ MORE

Drug Therapy for Demyelinating and Neuroinflammatory Diseases Given US Patent

Product News

MetP Pharma has announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its patent entitled “Treatment of Demyelinating Diseases”.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE